Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

FDA accepts for review the supplemental Biologics License Application for inhaled insulin (Afrezza) in children and adolescents aged 4-17 years living with diabetes – MannKind

Written by | 18 Oct 2025

MannKind Corporation announced that the  FDA has accepted the supplemental biologics license application (sBLA) seeking approval for Afrezza (insulin human) Inhalation Powder in children and adolescents living with… read more.

FDA submission of interoperable insulin pump in order to advance Medtronic and Abbott CGM partnership – Medtronic

Written by | 2 May 2025

Medtronic plc announced it has submitted 510(k) applications to the FDA seeking clearance for an interoperable pump. FDA clearance of this pump would pave the way for system integration… read more.

Insulet’s Omnipod 5 automated insulin delivery system improves clinical outcomes in type 1 diabetes

Written by | 28 Mar 2021

Insulet Corporation (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, announced positive results from the first pivotal trial… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.